Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection

for
Benign Neoplasm
Location: Corvallis OR
Sponsor: Samaritan Health Services

Sex: All

Age: 18+

Code: NCT05082441

Recruiting
Active & Responsive

Caris Biorepository Research Protocol

for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Ridge NY, Sparta NJ, Potsdam NY, Baltimore MD,
Sponsor: Caris Science, Inc.

Sex: All

Age: 18+

Code: NCT01499394

Recruiting
Active & Responsive

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: Rockport ME, Belfast ME, Damariscotta ME, Augusta ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07091617

Recruiting
Active & ResponsiveNew

A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor
Location: Seattle WA
Sponsor: Coherus Oncology, Inc.

Sex: Male

Age: 18+

Code: NCT07945821

Phase 1, Phase 2, Recruiting
Active & ResponsiveNew

XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors

for
Metastatic NSCLC - Non-Small Cell Lung Cancer,
Location: Fairfax VA, Canton OH, Fort Worth TX
Sponsor: Xilio Development, Inc.

Sex: All

Age: 18+

Code: NCT07688577

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

A Study of DS-3939a in Participants With Solid Tumors

for
Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer,
Location: Fairfax VA, Fayetteville AR
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07739966

Phase 1, Phase 2, Recruiting
Active & ResponsiveNew

A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal

for
Cancer
Location: Scarborough ME
Sponsor: Scot Remick

Sex: All

Age: 18+

Code: NCT07089225

Recruiting
Active & ResponsiveNew

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

for
Cancer
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07811258

Recruiting
Active & ResponsiveNew

Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease

for
Thyroid Eye Disease (TED), Graves' Disease,
Location: Wilmington NC, Orland Park IL
Sponsor: Ethyreal Bio, Inc.

Sex: All

Age: 18+

Code: NCT07885605

Phase 1, Recruiting
Active & Responsive

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for
Advanced Solid Tumor
Location: East Providence RI, Charleston SC, Huntersville NC,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06750185

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, New Haven CT, The Bronx NY, Montreal,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06619587

Phase 1, Recruiting
Active & Responsive

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: New Haven CT, Lake Success NY, New York NY, Fairfax VA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07361562

Phase 1, Recruiting
Active & Responsive

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

for
Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain,
Location: New York NY
Sponsor: Northwell Health

Sex: All

Age: 18 - 70+

Code: NCT03213002

Phase 1, Phase 2, Recruiting
Active & Responsive

UWCCC Molecular Tumor Board Registry

for
Hematologic Neoplasms, Solid Neoplasm
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT03023202

Recruiting
Active & Responsive

Biennial CEM in Women With a Personal History of Breast Cancer

for
Breast Cancer, Breast Neoplasms, Breast Cancer Female,
Location: Monroeville PA, West Mifflin PA, Pittsburgh PA,
Sponsor: Wendie Berg

Sex: Female

Age: 30 - 70+

Code: NCT06105749

Recruiting
Active & Responsive

68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

for
Solid Cancers
Location: Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sex: All

Age: 0+

Code: NCT05228106

Recruiting
Active & Responsive

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumor
Location: Canton OH, Cleveland OH
Sponsor: Lamassu Bio Inc

Sex: All

Age: 18+

Code: NCT06578624

Phase 1, Phase 2, Recruiting
Active & Responsive

Yoga for Young Adults Affected by Cancer

for
Young Adult Cancer, Young Adult Oncology
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT05314803

Recruiting
Active & Responsive

PAS-004 in Patients With Advanced Solid Tumors

for
RAS Mutation, NF1 Mutation, RAF Mutation, Advanced Solid Tumors
Location: Fairfax VA, San Antonio TX
Sponsor: Pasithea Therapeutics Corp.

Sex: All

Age: 18+

Code: NCT06299839

Phase 1, Recruiting
Active & Responsive

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06066424

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial